-
-
-
-
-
-
-
Affimed Announces IND Clearance for a Phase 2 Clinical Trial Investigating AFM13 and AB-101 Combination Therapy
-
-
-
-
-
-
-
After-Hours Stock Movers 11/09: (XPER) (FLGT) (HDS) Higher; (BYND) (NBIX) (TXMD) Lower (more...)
-
-
-
-
-
-
-
Pre-Open Movers 02/13: (GNC) (ABC) (UAA) Higher; (HMNY) (AFMD) (PDCO) (HSIC) Lower (more...)
-
-
-
-
-
-
1,157,930 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

